The effect of levamisole combined with the classical treatment in chronic brucellosis

Tohoku Journal of Experimental Medicine

Volumn 201, Issue 4, 2003, Pages 221-228

  Irmak, Hasan ^a   Buzgan, Turan ^a   Karahocagil, Mustafa Kasim ^a   Evirgen, Ömer ^a   Akdeniz, Hayrettin ^a   Demiröz, Ali Pekcan ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Chronic brucellosis; Levamisole; Treatment

Indexed keywords

C REACTIVE PROTEIN; DOXYCYCLINE; LEVAMISOLE; MERCAPTOETHANOL; RIFAMPICIN;

ADULT; AGGLUTINATION TEST; ARTHRALGIA; ARTICLE; BRUCELLOSIS; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COOMBS TEST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; STATISTICAL SIGNIFICANCE; SWEAT GLAND DISEASE;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGGLUTINATION TESTS; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTITUBERCULAR; ANTIBODIES, BACTERIAL; ANTINEMATODAL AGENTS; BONE MARROW; BRUCELLA MELITENSIS; BRUCELLOSIS; COMBINED MODALITY THERAPY; DOXYCYCLINE; FEMALE; HUMANS; LEVAMISOLE; MALE; MERCAPTOETHANOL; MIDDLE AGED; RIFAMPIN;

EID: 1642544753     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.201.221     Document Type: Article

References (23)

1. Akdeniz, H., Irmak, H. & Demiröz, A.P. (1998a) Evaluation of brucellosis cases in Van region of Eastern Anatolia: A-3 year experience. Nagoya Med. J., 42, 101-110.
2. Akdeniz, H., Irmak, H., Anlar, Ö. & Demiröz, A.P. (1998b) Central nervous system brucellosis presentation, diagnosis and treatment. J. Infect., 36, 297-301.
3. Akdeniz, H., Irmak, H., Seçkinli, T., Buzgan, T. & Demiröz, A.P. (1998c) Hematological manifestations in brucellosis cases in Turkey. Acta Med. Okayama, 52, 63-65.
4. Araj, G.F. & Kaufmann, A.F. (1989) Determination by enzyme-linked immunosorbent assay of immunoglobulin G (IgG), IgM and IgA to Brucella melitensis major outer membrane proteins and whole-cell heat-killed antigens in sera of patients with brucellosis. J. Clin. Microbiol., 27, 1909-1912.
5. Ariza, J., Pellicer, T., Pallares, R., Foz, A. & Gudiol, F. (1992) Specific antibody profile in human brucellosis. Clin. Infect. Dis., 14, 131-140.
6. Baldwin, C.L. (1996) Pathogenesis of brucellosis. In: Intracellular Bacterial Infections, edited by E.J. Pechere, 1st ed., Cambridge Med. Pub., West Sussex, pp. 87-92.
7. Boura, P., Raptopoulou, G.M., Acriviadis, E. & Goulis, G. (1984) Reevaluation of the effect of levamisole in chronic brucellosis: in vitro and in vivo effect on monocyte phagocytosis. J. Immunopharmacol., 6, 135-146.
8. Buchanan, T.M. & Faber, L.C. (1980) 2 Mercapto-ethanol brucella agglutination test: Usefulness for predicting recovery from brucellosis. J. Clin. Microbiol., 11, 691-693.
9. Çaksen, H., Odabaş, D., Arslan, Ş. & Öner, A.F. (2001) Central nervous system involvement in childhood brucellosis. J. Emerg. Med., 21, 291-292.
10. Çaksen, H., Arslan, Ş., Öner, A.F., Cesur, Y., Ceylan, A., Ataş, B. & Abuhandan, M. (2002) Childhood brucellosis is still a severe problem in the eastern region of Turkey. Trop. Doctor, 32, 91-92.
11. Corbel, M.J. (1989) Brucellosis: Epidemiology and prevalence worldwide. In: Brucellosis: Clinical and Laboratory Aspects, edited by E.J. Young and M.J. Corbel, CRC Press, Boca Raton, Fla. pp. 25-40.
12. Gazapo, E., Lahoz, J.G., Subiza, J.L., Baquero, M., Gil, J. & Concha, E.G. (1989) Changes in IgM and IgG antibody concentrations in brucellosis over time: importance for diagnosis and follow-up. J. Infect. Dis., 159, 219-225.
13. Gotuzzo, E. (1998) Brucella. In: Infectious Diseases, edited by S.L. Gorbach, J.G. Bartlett, N.R. Blacklow, 3rd ed., WB Saunders Co., Philadelphia, pp. 1837-1844.
14. Hall, W.H. (1991) Brucellosis. In: Bacterial Infections of Humans, edited by A.S. Evans, P.S. Brachman, 2nd ed., Plenum Publishing Corporation, New York, pp. 133-151.
15. Kayaalp, O. (1998) Tibbi Farmakoloji. 8th ed., Hacettepe TAŞ Kitabevi, Ankara (in Turkish), pp. 417.
16. Moyer, N.P. & Holcomb, L.A. (1995) Brucella. In: Manual of Clinical Microbiology, edited by P.R. Murray, E.J. Baron, M.A. Pfaller, F. C. Tenover & R.H. Yolken, ASM Press, Washington, pp. 549-553.
17. Mukovozova, L.A. (1986) Comparative effectiveness of levamisole and vaccine in the complex treatment of patients with brucellosis. Ter. Arkh., 58, 43-45.
18. Mukovozova, L.A. (1987) Efficacy of various methods of therapy of chronic brucellosis. Ter. Arkh., 59, 93-96.
19. Mukovozova, L.A. (1988) Effect of levamisole on the cellular and humoral immunity indices in patients with chronic brucellosis. Zh. Mikrobiol. Epidemiol. Immunobiol., 8, 98-101.
20. Pellicer, T., Ariza, J., Foz, A., Fallares, R. & Gudiol, F. (1987) Specific antibodies detected during relapse of human brucellosis. J. Infect. Dis., 157, 918-924.
21. Raptopoulou-Gigi, M., Kountouras, J. & Goulis, G. (1980) Levamisole in the treatment of chronic brucellosis. J. Imunopharmacol., 2, 85-97.
22. Young, E.J. (1991) Serologic diagnosis of human brucellosis: Analysis of 214 cases by agglutination tests and review of the literature. Rev. Infect. Dis., 13, 359-372.
23. Young, E.J. (2000) Brucella species. In: Principles and Practice of Infectious Diseases, edited by G.L. Mandell, J.E. Bennett & R. Dolin, 5th ed., Churchill Livingstone, New York, pp. 2386-2391.